Who we are
The Industry Liaison Forum (ILF) was founded by Joep Lange in 2001, when he was the President of the IAS. The purpose of ILF was to establish a partnership forum that could help mobilize commitment and maximize the combined resources in order to consider and address complex and inter-related research issues in the area of HIV/AIDS.
The ILF serves to help increase and improve the capacity for HIV-research and treatment for the many populations who remain grossly under-served by the benefits of clinical progress.
The establishment of the Industry Liaison Forum was supported by the following industry partners: Abbott Laboratories, Bayer Health Care, Boehringer Ingelheim, Bristol Myers Squibb, Gilead Sciences, GlaxoSmithKline Beecham, Merck, Pfizer, Roche Pharmaceuticals, Roche Diagnostics, Tibotec-Virco, Vertex, and Virologic.
ILF Advisory Group
The ILF is exemplary of a unique collaboration between stakeholders in the global response to HIV/AIDS and serves as a platform for creative thinking and constructive dialog around HIV research. The ILF Advisory Group consists of senior clinicians and public health experts from pharmaceutical and diagnostic industry, academia, NGOs, international organisations, and UN agencies.
Advisory Group Chairs
Celia Christie-Samuels, University of the West Indies, Jamaica (appointed 2010)
Sandra Lehrman, Merck, USA (appointed 2012)
Boris Renjifo, AbbVie, USA
Bryan Cobb, Roche Molecular Systems, USA
Catherine Hankins, Amsterdam Institute for Global Health and Development, The Netherlands
Cheryl Smith, Burkina Foundation, USA
Elly Katabira, Makerere University, Uganda (Former IAS President)
Heidi Nass, AIDS Treatment Activists Coalition, USA
James Rooney, Gilead Sciences, USA
Joel Gallant, John Hopkins University, USA
Linda-Gail Bekker, University of Cape Town, South Africa
Michael Rabbow, Boehringer Ingelheim, Germany
Nicholas Hellmann, Elizabeth Glaser Pediatric AIDS Foundation, USA
Perry Mohammed, Janssen, UK
Rahab Mwaniki, National Empowerment Network of People Living with HIV/AIDS, Kenya
Scott Purdon, ViiV Healthcare, UK
Bertrand Audoin, Executive Director, Switzerland
Bernard Kadasia, Senior Manager Partnerships - Director of Policy & Communications
Shirin Heidari, Senior Manager – Research Promotion, Switzerland
Sebastien Morin, ILF Research Officer, Switzerland
Former Chairs of ILF
Pedro Cahn (2007 - 2010)
Luc Denys (2009 - 2010)
Scott Hammer (2002 - 2003)
Elly Katabira (2006 - 2009)
Michel Kazatchkine (2002 - 2006)
Joep Lange (2002 - 2008)
Scott Purdon (2011-2012
Michael Rabbow (2008-2009)
Jim Rooney (2010 - 2011)
Robin Wood (2009-2012)
To see the ILF Advisory Group organigram, click here.
Terms of Reference
To read the ILF Advisory Group Terms of Reference, click here.
Working Group on Viral Load Monitoring in Resource-Limited Settings
To read the IAS-ILF Working Group on Viral Load Monitoring in Resource-Limited Settings Terms of Reference, click here